CA2387288A1 - Preparations pharmaceutiques anti-inflammatoires - Google Patents

Preparations pharmaceutiques anti-inflammatoires Download PDF

Info

Publication number
CA2387288A1
CA2387288A1 CA002387288A CA2387288A CA2387288A1 CA 2387288 A1 CA2387288 A1 CA 2387288A1 CA 002387288 A CA002387288 A CA 002387288A CA 2387288 A CA2387288 A CA 2387288A CA 2387288 A1 CA2387288 A1 CA 2387288A1
Authority
CA
Canada
Prior art keywords
dosage form
granules
nsaid
phthalate
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002387288A
Other languages
English (en)
Inventor
Austen John Woolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9923139.1A external-priority patent/GB9923139D0/en
Priority claimed from GB0000483A external-priority patent/GB0000483D0/en
Application filed by Individual filed Critical Individual
Publication of CA2387288A1 publication Critical patent/CA2387288A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une forme de dosage pharmaceutique à usage buccal comprenant un mélange d'une préparation à libération différée d'un médicament anti-inflammatoire non stéroïdien (NSAID) et un mélange renfermant une prostaglandine et au moins un excipient.
CA002387288A 1999-10-01 2000-09-29 Preparations pharmaceutiques anti-inflammatoires Abandoned CA2387288A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9923139.1 1999-10-01
GBGB9923139.1A GB9923139D0 (en) 1999-10-01 1999-10-01 Anti-inflammatory pharmaceutical formulations
GB0000483A GB0000483D0 (en) 2000-01-11 2000-01-11 Anti-inflammatory pharmaceutical formulations
GB0000483.8 2000-01-11
PCT/GB2000/003729 WO2001024778A1 (fr) 1999-10-01 2000-09-29 Preparations pharmaceutiques anti-inflammatoires

Publications (1)

Publication Number Publication Date
CA2387288A1 true CA2387288A1 (fr) 2001-04-12

Family

ID=26243367

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002387288A Abandoned CA2387288A1 (fr) 1999-10-01 2000-09-29 Preparations pharmaceutiques anti-inflammatoires

Country Status (6)

Country Link
EP (1) EP1216030A1 (fr)
JP (1) JP2003510347A (fr)
KR (1) KR20020063871A (fr)
AU (1) AU7537000A (fr)
CA (1) CA2387288A1 (fr)
WO (1) WO2001024778A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
CN1665514A (zh) * 2002-07-02 2005-09-07 若素制药株式会社 治疗或预防角结膜上皮细胞损伤的药物
WO2004091579A1 (fr) * 2003-04-16 2004-10-28 Pharmacia Corporation Formulation de prostaglandine stabilisee
EP1987820A1 (fr) * 2007-05-04 2008-11-05 Christian Fiala, Ph. D. Misoprostole à libération lente pour applications obstétriques et/ou gynécologiques
EP2167048B1 (fr) 2007-05-30 2016-10-26 Wockhardt Limited Nouvelle forme posologique de comprimé
CN110893174A (zh) * 2019-12-04 2020-03-20 仁和堂药业有限公司 双氯芬酸钠肠溶片的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016895A1 (fr) * 1990-05-03 1991-11-14 G.D. Searle & Co. Composition pharmaceutique
WO1991016886A1 (fr) * 1990-05-03 1991-11-14 G.D. Searle & Co. Composition pharmaceutique contenant de l'ibuprofene ainsi qu'une prostaglandine
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
GB9814215D0 (en) * 1998-07-01 1998-09-02 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
GB9819685D0 (en) * 1998-09-10 1998-11-04 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
CA2259727A1 (fr) * 1999-01-18 2000-07-18 Bernard Charles Sherman Pastille pharmaceutique a deux couches comprenant un ains et du misoprostol
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
CA2277407A1 (fr) * 1999-07-14 2001-01-14 Bernard Charles Sherman Comprime comprenant un ains et du misoprostol

Also Published As

Publication number Publication date
AU7537000A (en) 2001-05-10
WO2001024778A1 (fr) 2001-04-12
EP1216030A1 (fr) 2002-06-26
KR20020063871A (ko) 2002-08-05
JP2003510347A (ja) 2003-03-18

Similar Documents

Publication Publication Date Title
US6787155B2 (en) Anti-inflammatory pharmaceutical formulations
US6027748A (en) Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
JP3157182B2 (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
US20090208575A1 (en) Pharmaceutical Composition Of Acid Labile Substances
WO2004064815A1 (fr) Formulation de dosage oral
KR20080070841A (ko) 아세틸 살리실산과 함께 프로톤 펌프 억제제를 활성성분으로 포함하는 경구용 약제학적 투약형
US6319519B2 (en) Anti-inflammatory pharmaceutical formulations
KR20160124368A (ko) 프로피온산 계열의 비스테로이드성 항염증 약물(nsaid) 및 프로톤 펌프 저해제(ppi)를 함유하는 생체이용률이 증진된 약제학적 조성물
EP1091731B1 (fr) Formulations pharmaceutiques anti-inflammatoires
JPH0157090B2 (fr)
KR20190092805A (ko) 아세틸살리실산 및 란소프라졸을 포함하는 약학적 조성물
CA2387288A1 (fr) Preparations pharmaceutiques anti-inflammatoires
WO2004062552A2 (fr) Composition pharmaceutique contenant un ains et un derive benzimidazole
US20090022786A1 (en) Oral pharmaceutical dosage form and manufacturing method thereof
EP1109538B1 (fr) Preparations pharmaceutiques anti-inflammatoires
US20020090395A1 (en) Anti-inflammatory pharmaceutical formulations
EP4069207A1 (fr) Compositions pharmaceutiques à libération modifiée de riociguat
US6514525B2 (en) Anti-inflammatory pharmaceutical formulations
KR20150114657A (ko) 일라프라졸 및 비스테로이드성 항염증약물 또는 이의 약학적으로 허용 가능한 염을 포함하는 약제학적 복합제제 및 이의 제조방법
EA012296B1 (ru) Фармацевтическая композиция с контролируемым высвобождением, содержащая не растворимый в кислотах полимер и биоадгезивный полимер
JPS63243030A (ja) 持効性セフラジン製剤
JP2005510449A (ja) 改良型制御放出経口剤形
MX2008006727A (en) Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid

Legal Events

Date Code Title Description
FZDE Dead